Stuart Hossack

409 total citations
10 papers, 319 citations indexed

About

Stuart Hossack is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Nephrology. According to data from OpenAlex, Stuart Hossack has authored 10 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Physiology and 2 papers in Nephrology. Recurrent topics in Stuart Hossack's work include Air Quality and Health Impacts (2 papers), Electrolyte and hormonal disorders (2 papers) and Parathyroid Disorders and Treatments (2 papers). Stuart Hossack is often cited by papers focused on Air Quality and Health Impacts (2 papers), Electrolyte and hormonal disorders (2 papers) and Parathyroid Disorders and Treatments (2 papers). Stuart Hossack collaborates with scholars based in United Kingdom, United States and Belgium. Stuart Hossack's co-authors include David A. Engers, John Thomson, Igor Ivanisevic, A.G.B. Templeton, Ann Newman, C. P. Campbell, Stephen R. Byrn, Jing Teng, David M. Pierce and Patrick Martin and has published in prestigious journals such as British Journal of Cancer, Journal of Pharmaceutical Sciences and BMC Public Health.

In The Last Decade

Stuart Hossack

10 papers receiving 306 citations

Peers

Countries citing papers authored by Stuart Hossack

Since Specialization

Citations

This map shows the geographic impact of Stuart Hossack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Hossack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Hossack more than expected).

Fields of papers citing papers by Stuart Hossack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart Hossack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Hossack. The network helps show where Stuart Hossack may publish in the future.

Co-authorship network of co-authors of Stuart Hossack

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart Hossack. A scholar is included among the top collaborators of Stuart Hossack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart Hossack. Stuart Hossack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	CYP11B2 inhibitor dexfadrostat phosphate suppresses the aldosterone‐to‐renin ratio, an indicator of sodium retention, in healthy volunteers 2023 ·British Journal of Clinical Pharmacology ·Paolo Mulatero, Michael Groessl, Bruno Vogt, Christoph Schumacher, Ronald E. Steele, Ashley Brooks, Stuart Hossack, (unknown)	18
2	Changes in Biomarkers of Exposure on Switching From a Conventional Cigarette to Tobacco Heating Products: A Randomized, Controlled Study in Healthy Japanese Subjects 2018 ·Nicotine & Tobacco Research ·Nathan Gale, Michael McEwan, Alison Eldridge, Ian M. Fearon, N. Sherwood, (unknown), (unknown), (unknown), (unknown), Stuart Hossack, (unknown), (unknown), Oscar M. Camacho, Graham Errington, John McAughey, James J. Murphy, Chuan Liu, Christopher Proctor	70
3	Safety, Pharmacokinetics, and Pharmacodynamics Study in Healthy Subjects of Oral NEO6860, a Modality Selective Transient Receptor Potential Vanilloid Subtype 1 Antagonist 2017 ·Journal of Pain ·W. A. Brown, Richard L. Leff, Andrew M. Griffin, Stuart Hossack, (unknown), Philippe Walker, D. Chiche	42
4	A randomised, controlled, two-Centre open-label study in healthy Japanese subjects to evaluate the effect on biomarkers of exposure of switching from a conventional cigarette to a tobacco heating product 2017 ·BMC Public Health ·Nathan Gale, Michael McEwan, Alison Eldridge, N. Sherwood, (unknown), (unknown), (unknown), (unknown), Stuart Hossack, Oscar M. Camacho, Graham Errington, John McAughey, James J. Murphy, Chuan Liu, Christopher Proctor, Ian M. Fearon	18
5	SELECT-3: a phase I study of selumetinib in combination with platinum-doublet chemotherapy for advanced NSCLC in the first-line setting 2017 ·British Journal of Cancer ·Alastair Greystoke, Nicola Steele, Hendrik‐Tobias Arkenau, Fiona Blackhall, (unknown), Colin R. Lindsay, Raffaele Califano, Mark Voskoboynik, Yvonne Summers, Karen So, Dana Ghiorghiu, (unknown), Stuart Hossack, Ruth Plummer, Emma Dean	22
6	Randomized clinical trial: pharmacokinetics and safety of multimatrix mesalamine for treatment of pediatric ulcerative colitis 2016 ·Drug Design Development and Therapy ·Carmen Cuffari, David M. Pierce, Bartosz Korczowski, (unknown), (unknown), Stuart Hossack, Hong Wan, (unknown), Paul T. Martin	8
7	A phase 1 randomized study evaluating the effect of omeprazole on the pharmacokinetics of a novel 5-hydroxytryptamine receptor 4 agonist, revexepride (SSP-002358), in healthy adults 2015 ·Drug Design Development and Therapy ·Paul T. Martin, David M. Pierce, Mary Corcoran, Maria Velinova, Stuart Hossack, Mieke Hoppenbrouwers	4
8	Assessment of Pharmacodynamic Equivalence and Tolerability of Lanthanum Carbonate Oral Powder and Tablet Formulations: A Single-Center, Randomized, Open-Label, 2-Period Crossover Study in Healthy Subjects 2012 ·Clinical Therapeutics ·David M. Pierce, Stuart Hossack, (unknown), (unknown), Patrick Martin	12
9	The effect of sevelamer carbonate and lanthanum carbonate on the pharmacokinetics of oral calcitriol 2010 ·Nephrology Dialysis Transplantation ·David M. Pierce, Stuart Hossack, Lona Poole, Andrew Robinson, (unknown), Patrick Martin, Michael Smyth	29
10	A Solid-State Approach to Enable Early Development Compounds: Selection and Animsal Bioavailability Studies of an Itraconazole Amorphous Solid Dispersion 2010 ·Journal of Pharmaceutical Sciences ·David A. Engers, Jing Teng, (unknown), (unknown), Stuart Hossack, C. P. Campbell, John Thomson, Igor Ivanisevic, A.G.B. Templeton, Stephen R. Byrn, Ann Newman	96

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact